Education
About Us
Working with TipRanks
Follow Us
CSPC Pharmaceutical Group Limited (HK:1093)
:1093
RESEARCH TOOLSreports
Total Valuation
CSPC Pharmaceutical Group has a market cap or net worth of $69.61B. The enterprise value is ―.
Market Cap$69.61B
Enterprise Value―
Share Statistics
CSPC Pharmaceutical Group has 11,543,702,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,543,702,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CSPC Pharmaceutical Group’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 17.20%.
Return on Equity (ROE)0.20
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)17.20%
Return on Capital Employed (ROCE)0.21
Revenue Per Employee1.62M
Profits Per Employee345.30K
Employee Count21,400
Asset Turnover0.75
Inventory Turnover3.25
Valuation Ratios
The current PE Ratio of CSPC Pharmaceutical Group is 13.30. CSPC Pharmaceutical Group’s PEG ratio is 2.16.
PE Ratio13.30
PS Ratio0.00
PB Ratio2.60
Price to Fair Value2.60
Price to FCF34.17
Price to Operating Cash Flow18.69
PEG Ratio2.16
Income Statement
In the last 12 months, CSPC Pharmaceutical Group had revenue of 34.60B and earned 5.87B in profits. Earnings per share was 0.55.
Revenue34.60B
Gross Profit24.40B
Operating Income7.68B
Pretax Income7.39B
Net Income5.87B
EBITDA8.53B
Earnings Per Share (EPS)0.55
Cash Flow
In the last 12 months, operating cash flow was 4.27B and capital expenditures -1.54B, giving a free cash flow of 2.73B billion.
Operating Cash Flow4.27B
Free Cash Flow2.73B
Free Cash Flow per Share0.24
Dividends & Yields
CSPC Pharmaceutical Group pays an annual dividend of HK$0.1, resulting in a dividend yield of 5.99%
Dividend Per ShareHK$0.1
Dividend Yield5.99%
Payout Ratio35.73%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.97
52-Week Price Change-1.46%
50-Day Moving Average5.09
200-Day Moving Average5.20
Relative Strength Index (RSI)64.33
Average Volume (3m)153.56M
Important Dates
CSPC Pharmaceutical Group upcoming earnings date is May 21, 2025, TBA Not Confirmed.
Last Earnings DateMar 28, 2025
Next Earnings DateMay 21, 2025
Ex-Dividend DateJun 04, 2025
Financial Position
CSPC Pharmaceutical Group as a current ratio of 2.63, with Debt / Equity ratio of 1.12%
Current Ratio2.63
Quick Ratio2.32
Debt to Market Cap<0.01
Net Debt to EBITDA-1.33
Interest Coverage Ratio296.58
Taxes
In the past 12 months, CSPC Pharmaceutical Group has paid 1.32B in taxes.
Income Tax1.32B
Effective Tax Rate0.18
Enterprise Valuation
CSPC Pharmaceutical Group EV to EBITDA ratio is 7.83, with an EV/FCF ratio of 29.22.
EV to Sales1.93
EV to EBITDA7.83
EV to Free Cash Flow29.22
EV to Operating Cash Flow15.98
Balance Sheet
CSPC Pharmaceutical Group has $10.81B in cash and marketable securities with ¥1.30B in debt, giving a net cash position of -$10.42B billion.
Cash & Marketable Securities$10.81B
Total Debt¥1.30B
Net Cash-$10.42B
Net Cash Per Share-$0.90
Tangible Book Value Per Share$2.74
Margins
Gross margin is 71.38%, with operating margin of 22.20%, and net profit margin of 16.98%.
Gross Margin71.38%
Operating Margin22.20%
Pretax Margin21.36%
Net Profit Margin16.98%
EBITDA Margin24.66%
EBIT Margin21.43%
Analyst Forecast
The average price target for CSPC Pharmaceutical Group is $5.74, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5.74
Price Target Upside-4.94% Downside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast-9.60%
EPS Growth Forecast-26.94%